MedPath

Glutamine supplementation guided by plasma glutamine levels

Withdrawn
Conditions
voeding supplementen
glutamine
Registration Number
NL-OMON42972
Lead Sponsor
Medisch Centrum Leeuwarden
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

All patients admitted to the ICU with an expected stay of 48 hours or longer

Exclusion Criteria

age under 18 years, readmission to the ICU, contra-indication for enteral nutrition and the use of Total Parental Nutrition

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Is there a difference in length of mechanical ventilation, length of stay ICU<br /><br>or length of stay hospital between patients who received enteral glutamine or<br /><br>not?</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>What is the amount of enteral glutamine supplementation needed to increase the<br /><br>plasma glutamine level to a level above 420 µmol/l.Is there a difference<br /><br>between hospital mortality or 6 month mortality between patients who received<br /><br>enteral glutamine or not?<br /><br>Is there a relationship between nutritional status ( measured with<br /><br>bio-impedance vector analysis) and plasma glutamine level?<br /><br>Is there a relationship between the amount of supplied nutrition and the course<br /><br>of plasma glutamine levels?<br /><br>Is there a difference between patients admitted with sepsis or trauma compared<br /><br>to other causes of admission?</p><br>
© Copyright 2025. All Rights Reserved by MedPath